Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $123.76 --0%
EPS Growth %: -462.7%
Financial Fact:
Product sales: 7.41B
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -462.7%
Financial Fact:
Product sales: 7.41B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $1.00, $0.01 better than the analyst estimate of $0.99. Revenue for the quarter came in at $2.14 billion versus the consensus estimate of $2.07 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald: Yeztugo Total TRx Down
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- CarMax beats estimates as new strategy drives early results
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
